• Amyloid removal may reduce tau buildup and neurodegeneration in Alzheimer’s disease July 13, 2026 In an Alzheimer’s disease patient’s brain, regions cleared of amyloid had little tau; nearby areas with persistent amyloid had greater signs of damage.
• Novel medicine for rare disease prompts $10M gift for trials July 06, 2026 The Clayco Foundation award will go toward safety trials of a new small molecule drug aimed at treating RVCL, a rare, fatal disease with no cure.
• A model global health academic partnership flourishes in Botswana July 06, 2026 The Botswana-UPenn Partnership has surpassed its goal of addressing HIV/AIDS and has broadened its scope to enhance national access to care and training.
• AI framework aids target discovery for CAR T cell therapy June 24, 2026 The customizable, human-in-the-loop AI framework uses public data to find viable target antigens for CAR T cell therapy.
• CAR T cell therapy leads to 10-year remissions in B-cell lymphoma patients June 23, 2026 Many patients with large B-cell lymphoma or follicular lymphoma were still living without a relapse, 10 years after receiving CAR T therapy.

Use arrow keys to view news

Use arrow keys to view events